Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Xerostom saliva substitute gel
1203050A0BIADAP
|
Xerostom | Artificial saliva products | Ear, Nose and Oropharynx | 44 |
|
Xerostom mouthwash
1203050A0BIABAM
|
Xerostom | Artificial saliva products | Ear, Nose and Oropharynx | 37 |
|
Xerostom toothpaste
1203050A0BIAEAQ
|
Xerostom | Artificial saliva products | Ear, Nose and Oropharynx | 28 |
|
Xerostom pastilles
1203050A0BIACAN
|
Xerostom | Artificial saliva products | Ear, Nose and Oropharynx | 11 |
|
Xerostom chewable capsules
1203050A0BIAFAR
|
Xerostom | Artificial saliva products | Ear, Nose and Oropharynx | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.